GPT and hepatocellular carcinoma: Treatment with canagliflozin (Cana) at 10 mg/kg and 20 mg/kg reduced ALT levels to 57.5% and 46.7% of the HCC group, respectively, with the high dose showing a more significant reduction (p ≤ 0.05).